Could cell‐free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?. Issue 5 (18th October 2022)

• Record Type: Journal Article
• Authors: Chang, Sandy Y.; Santos, Carlos A. Q.
• Other Names: Forrest Graeme guestEditor.; Husain Shahid guestEditor.
• Is Part Of: Transplant infectious disease. Volume 24:Issue 5(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-10-18
• Subjects: antimicrobial stewardship -- cell‐free DNA -- gene expression profiling -- solid organ transplant; Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.13971
• Languages: English
• ISSNs: 1398-2273

Abstract

Abstract: Background: Antimicrobial stewardship in solid organ transplant (SOT) recipients is important to prevent antimicrobial‐associated complications, but traditional stewardship principles are challenging to implement for SOT patients. Newer methodologies to optimize stewardship efforts are needed. Methods: PubMed was searched using the keywords "cell free DNA, " "metagenomic sequencing, " "host biomarker, " "antimicrobial stewardship, " and "SOT." Results: Metagenomic sequencing of cell free DNA has the potential to be a stewardship tool for SOT recipients. Various studies have shown its use for antimicrobial de‐escalation and duration shortening. Host gene expression profiles can differentiate between infectious and noninfectious syndromes and may assist in stewardship efforts. However, information in immunocompromised hosts is conflicting. Conclusion: Microbial cell free DNA sequencing and host gene expression profiling show promise as stewardship tools in SOT recipients. Future studies on antimicrobial stewardship in SOT recipients should focus on their clinical use and feasibility.